4DONCASTER PCN — All Prescriptions & Medications
Practice Code: Y06243 | DONCASTER, DN4 8QN
Over the last 12 months, 4DONCASTER PCN prescribed 1,456 items across 28 different medications at a total cost of £4,977 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Amoxicillin | 279 | 6,447 | £269 | -70.1% ▼ |
| Doxycycline hyclate | 152 | 1,287 | £119 | -70.3% ▼ |
| Lansoprazole | 78 | 3,210 | £113 | -98.3% ▼ |
| Prednisolone | 77 | 2,751 | £69 | -90.4% ▼ |
| Salbutamol | 55 | 58 | £137 | -97.8% ▼ |
| Flucloxacillin sodium | 53 | 1,684 | £112 | -88.2% ▼ |
| Hydrocortisone | 47 | 1,075 | £282 | -89.5% ▼ |
| Betamethasone valerate | 46 | 2,900 | £167 | -88.1% ▼ |
| Naproxen | 39 | 1,624 | £211 | -96.0% ▼ |
| 30 | 15.4K | £156 | -97.0% ▼ | |
| Dexamethasone | 28 | 155 | £97 | -83.7% ▼ |
| Mometasone furoate | 25 | 25 | £184 | -93.8% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 24 | 1,560 | £61 | -92.2% ▼ |
| Clarithromycin | 24 | 556 | £109 | -90.2% ▼ |
| Co-codamol (Codeine phosphate/paracetamol) | 23 | 1,408 | £55 | -98.8% ▼ |
| Fexofenadine hydrochloride | 22 | 718 | £32 | -97.4% ▼ |
| 22 | 24 | £144 | -90.7% ▼ | |
| Nitrofurantoin | 21 | 212 | £124 | -95.6% ▼ |
| Beclometasone dipropionate | 18 | 18 | £318 | -99.0% ▼ |
| Fusidic acid | 18 | 285 | £38 | -85.9% ▼ |
| Nystatin | 15 | 510 | £29 | -85.1% ▼ |
| Benzoyl peroxide and clindamycin phosphate | 14 | 510 | £210 | -79.1% ▼ |
| Clotrimazole | 14 | 450 | £25 | -85.6% ▼ |
| Codeine phosphate | 13 | 592 | £19 | -98.2% ▼ |
| Neomycin sulfate | 12 | 180 | £23 | -79.8% ▼ |
| Omeprazole | 11 | 336 | £34 | -99.8% ▼ |
| Prochlorperazine maleate | 11 | 422 | £23 | -94.6% ▼ |
| Hydrocortisone | 10 | 216 | £65 | -86.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.